Digital
22nd - 23rd April, 2021

4th Annual MarketsandMarkets Real-World Data, Life Sciences Analytics and Market Access Virtual Conference (Time Zone - EST)

MarketsandMarkets is proud to announce the 4th Annual MarketsandMarkets Real-World Data, Life Sciences Analytics and Market Access Virtual Conference to be held on 22- 23 April, 2021.

While the 3rd annual virtual conference had discussions on how the insights derived from real world data, as well as acknowledgment of the effect the insights can have on improving decision making and patient consideration both internally and by regulators, doctors, and payers, the 4th Annual conference will focus on discussion about the application of RWD/RWE across the life cycle. The event will discuss Impact of COVID-19 on the real-world generation and making sense of the Electronic Health Records data for COVID-19.

Our aim for the 4th Annual Virtual Conference is to unite all stakeholders in a virtual room to learn how to overcome the challenges caused due to the pandemic, efficiently and effectively generating RWE for stakeholders including payers, patients and physicians.

WHAT TO EXPECT

Key Highlights

  

  • Real-world data- Demonstrating value for all stakeholders
  • Managing the big data available including the COVID data
  • Relation between real-world evidence and clinical development
  • Real-world evidence supporting patient access
  • Importance of PRO
  • Attaining uniformity in data in all clinical parameters for better comparison

  

Why Attend?

  • Learn about the recent trends and advancements in Real-World Evidence Generation
  • Engage in meaningful discussion with the most prominent industry experts and decision makers from pharmaceutical and biopharmaceutical companies who will address most critical challenges in real-world data and real-world evidence space.
  • Opportunity to network and exchange scientific knowledge with expert speakers from leading pharmaceutical companies, global regulators, and solution providers

Who Should Attend?

  • From Pharmaceutical and Biopharmaceutical companies

    Chief executives, VP’s, Directors, Global heads, Heads, Leaders, Senior Managers, Researcher, Analysts, Investigators, Scientists, Bio-Statisticians, Epidemiologists, within the following departments-

  • Real-World Evidence
  • Health Economics & Outcomes Research
  • Market Access
  • Value Access
  • Clinical Outcomes
  • Clinical Development
  • Center for Observational and Real-World Evidence  

CONFERENCE AGENDA
CONFERENCE SPEAKERS
Advisors
Charles Makin
Charles Makin
Global Head, Real World Evidence Strategy , Biogen
 Luis Prieto
Luis Prieto
Director Real World Evidence - Global Medical Affairs, Immunology, Hepatology & Dermatology, Novartis
Eliza Kruger
Eliza Kruger
Associate Director, Global HEOR, Ultragenyx Pharmaceuticals
Speakers
Charles Makin
Charles Makin
Global Head, Real World Evidence Strategy , Biogen
Lucy Pan
Lucy Pan
Director and Strategy Lead, Global Evidence & Value Development, EMD Serono
Nirosha Mahendraratnam Lederer
Nirosha Mahendraratnam Lederer
,
Georges De Feu
Georges De Feu
Founder & CEO, Lynxcare
Nneka Onwudiwe
Nneka Onwudiwe
Former PRO/PE Regulatory Review Officer, FOOD AND DRUG ADMINISTRATION
Myla Maloney
Myla Maloney
Vice President, Strategy and Commercial Operations, Premier Applied Sciences
Usha Periyanayagam
Usha Periyanayagam
Head of Clinical Product and RWE, Komodo Health
Tao Fan
Tao Fan
Senior Director, US HEOR US Medical Office , Takeda Pharmaceuticals
SPONSORS
Platinium
example-image

Komodo Health

Sponsors & Exhibitors
example-image

Picnic Health

example-image

Adelphi Real World

example-image

Premier Inc.

Speaking Partner
example-image

RTI Health Solutions

example-image

Aetion

example-image

LynxCare

PARTNERS
Media Partners
example-image

PharmaVOICE

example-image

PharmaTutor

example-image

Pharma Journalist

PAST EVENT GALLERY